Response to Fisher et al.
W
e read with interest the recent article by Fisher et al. (1) that concluded that subthreshold depression could be regarded as a proxy marker of diabetes-related distress rather than a proxy marker of clinical depression. Fisher et al. support their conclusion by referring to two key findings of their study. Their first finding was a markedly higher correlation between diabetes-related distress and the intensity of depressive symptoms than that between diabetes-related distress and clinical depression. Their second finding was significant associations between subthreshold depression and both poor glycemic control and diabetes-related behaviors (but these risk factors were unrelated to clinical depression). Our comments regarding this study address recommendations for screening emotional problems like depression and diabetes-related distress.
In our own study (2), we showed that the assessment of diabetes-related distress using the Problem Areas of Diabetes (PAID) scale has two key advantages. First, of 53 diabetic patients with clinical depression, 43 could be correctly identified by assessing diabetes-related distress (sensitivity 81.1%). The PAID scale also demonstrated good screening performance for detecting subclinical depression, as 99 of 124 diabetic patients with subclinical or clinical depression were correctly identified (sensitivity 79.0%). Second, the use of depression questionnaires to identify diabetic patients with a high diabetes-related distress (PAID score Ͼ40) resulted in a rather poor screening performance of both the Beck Depression Inventory (which correctly identified 70 of 116 patients; sensitivity 60.3%) and the Center for Epidemiological Studies Depression Scale (which correctly identified 60 of 116 patients; sensitivity 49.1%). Thus, diabetes-related distress used as a screener for clinical and subclinical depression demonstrated a reasonable screening performance comparable to that of depression questionnaires; however, the use of depression questionnaires to identify patients with high diabetesrelated distress would have missed 40 -50% of diabetic patients burdened with a high amount of diabetes-specific distress.
Another argument could be derived from intervention studies. Diabetes education, which can be regarded as a method to increase patients' ability to cope with diabetes-related distress, has proved to markedly reduce the proportion of subclinically depressed diabetic patients (3) . This outcome would also support the findings of Fisher et al. (1) that subclinical depression appears to be more closely related to diabetes-related distress than clinical depression.
Thus, because multiple screening in clinical practice is hardly feasible, it seems reasonable to use diabetes-related distress measures only to screen for depression in diabetic patients and to assess diabetesrelated strain. Furthermore, asking patients about diabetes-related distress might be better suited to meeting patients' expectations regarding seeking treatment for diabetes. 
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